搜索临床试验以:89Zr-girentuximab(89Zirconium-girentuximab)
总计127个结果
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
BioNTech Research & Development, Inc.SciQuus Oncology终止
-
Karolinska University Hospital招聘中
-
Monopar Therapeutics招聘中
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Broad Institute完全的
-
Millennium Pharmaceuticals, Inc.终止
-
Amsterdam UMC, location VUmcBristol-Myers Squibb招聘中
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
University Medical Center GroningenHoffmann-La Roche; Amsterdam UMC, location VUmc; Stichting Hemato-Oncologie voor Volwassenen Nederland撤销
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)未知
-
Aplagon OyTRACER Europe BV招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Crescendo Biologics Ltd.University Medical Center Groningen主动,不招人
-
Memorial Sloan Kettering Cancer Center撤销
-
Institut de Recherches Internationales ServierADIR, a Servier Group company招聘中
-
Memorial Sloan Kettering Cancer Center完全的
-
University Medical Center GroningenNovartis Pharmaceuticals完全的
-
University of Alabama at Birmingham撤销
-
Washington University School of MedicineMolecular Templates, Inc.撤销HER2阳性实体瘤 | HER-2阳性癌症
-
Boehringer Ingelheim终止
-
University of Alabama at Birmingham招聘中
-
The Netherlands Cancer InstituteDaiichi Sankyo, Inc.尚未招聘表皮生长因子受体基因突变 | 非小细胞肺癌 | 晚期非小细胞鳞状肺癌
-
Amsterdam UMC, location VUmcAstraZeneca招聘中乳腺癌 | 胃癌 | 转移性乳腺癌 | HER2阳性乳腺癌 | HER2阳性胃癌 | 转移性胃癌荷兰
-
University Medical Center GroningenNovartis完全的
-
University Medical Center GroningenVHL Alliance完全的肾细胞癌 | 冯·希佩尔-林道病 | 嗜铬细胞瘤 | 胰腺神经内分泌肿瘤 | 血管母细胞瘤荷兰
-
Robert Flavell, MD, PhDUnited States Department of Defense; Fortis Therapeutics, Inc.招聘中
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)招聘中